Local blockade of IL-6R signaling induces lung CD4+ T cell apoptosis in a murine model of asthma via regulatory T cells - PubMed (original) (raw)
doi: 10.1093/intimm/dxm037. Epub 2007 May 11.
Tatjana Eigenbrod, Roman Karwot, Ildiko Boross, Aysefa Doganci, Hiroaki Ito, Norihiro Nishimoto, Kazuyuki Yoshizaki, Tadamitsu Kishimoto, Stefan Rose-John, Peter R Galle, Markus F Neurath
Affiliations
- PMID: 17496315
- DOI: 10.1093/intimm/dxm037
Local blockade of IL-6R signaling induces lung CD4+ T cell apoptosis in a murine model of asthma via regulatory T cells
Susetta Finotto et al. Int Immunol. 2007 Jun.
Abstract
We previously reported high levels of the soluble form of the IL-6R (sIL-6R) in the airways of asthmatic subjects. Here, we analyzed the IL-6R effects on Th2 cell survival in the lung by locally antagonizing sIL-6R-mediated trans-signaling with a designer fusion protein (gp130-Fc) as well as IL-6R signaling with an antibody against the gp80 unit of the IL-6R (alphaIL-6R) in a murine model of asthma after ovalbumin peptide (OVA) sensitization and challenge. Blockade of the sIL-6R led to a significant decrease in inflammatory cells by an apoptosis-independent mechanism. In contrast, local treatment with alphaIL-6R antibodies that also block signaling via the membrane-bound IL-6R (mIL-6R) led to decreased signal transducers and activators of transcription (STAT)-3 but not STAT-1 phosphorylation in the lung of treated mice as compared with control-treated mice. Moreover, this treatment induced apoptosis of the cells present in the airways of OVA-treated mice as well as apoptosis of lung CD4+ effector T cells. Subsequent studies showed that this effect was mediated by lung CD4+CD25+Foxp3+ T regulatory cells by a cell-cell interaction, thereby contributing to the resolution of airway hyperresponsiveness in OVA-treated mice given anti-IL-6R antibodies. Taken together, these data suggest that blockade of mIL-6R signaling leads to cell death of lung effector T cells by activating regulatory T cells in experimental asthma. Local targeting of IL-6R signaling could be a novel approach for inducing Th2 T cell death in allergic airways via regulatory T cells.
Similar articles
- IL-6-gp130-STAT3 in T cells directs the development of IL-17+ Th with a minimum effect on that of Treg in the steady state.
Nishihara M, Ogura H, Ueda N, Tsuruoka M, Kitabayashi C, Tsuji F, Aono H, Ishihara K, Huseby E, Betz UA, Murakami M, Hirano T. Nishihara M, et al. Int Immunol. 2007 Jun;19(6):695-702. doi: 10.1093/intimm/dxm045. Epub 2007 May 9. Int Immunol. 2007. PMID: 17493959 - Blockade of interleukin 6 trans signaling suppresses T-cell resistance against apoptosis in chronic intestinal inflammation: evidence in crohn disease and experimental colitis in vivo.
Atreya R, Mudter J, Finotto S, Müllberg J, Jostock T, Wirtz S, Schütz M, Bartsch B, Holtmann M, Becker C, Strand D, Czaja J, Schlaak JF, Lehr HA, Autschbach F, Schürmann G, Nishimoto N, Yoshizaki K, Ito H, Kishimoto T, Galle PR, Rose-John S, Neurath MF. Atreya R, et al. Nat Med. 2000 May;6(5):583-8. doi: 10.1038/75068. Nat Med. 2000. PMID: 10802717 - Schistosoma japonicum egg antigens stimulate CD4 CD25 T cells and modulate airway inflammation in a murine model of asthma.
Yang J, Zhao J, Yang Y, Zhang L, Yang X, Zhu X, Ji M, Sun N, Su C. Yang J, et al. Immunology. 2007 Jan;120(1):8-18. doi: 10.1111/j.1365-2567.2006.02472.x. Epub 2006 Oct 17. Immunology. 2007. PMID: 17042799 Free PMC article. - Pathological role of IL-6 in the experimental allergic bronchial asthma in mice.
Doganci A, Sauer K, Karwot R, Finotto S. Doganci A, et al. Clin Rev Allergy Immunol. 2005 Jun;28(3):257-70. doi: 10.1385/CRIAI:28:3:257. Clin Rev Allergy Immunol. 2005. PMID: 16129910 Review. - Interleukin-6 trans-signaling in inflammatory bowel disease.
Mitsuyama K, Sata M, Rose-John S. Mitsuyama K, et al. Cytokine Growth Factor Rev. 2006 Dec;17(6):451-61. doi: 10.1016/j.cytogfr.2006.09.003. Epub 2006 Oct 12. Cytokine Growth Factor Rev. 2006. PMID: 17045835 Review.
Cited by
- Interleukin‑27 ameliorates allergic asthma by alleviating the lung Th2 inflammatory environment.
Lu J, Ji X, Wang L, Sun F, Huang C, Peng H, Jiang Y, Guo Z, Liu X, Ji Y, Lu D. Lu J, et al. Int J Mol Med. 2022 Jun;49(6):86. doi: 10.3892/ijmm.2022.5142. Epub 2022 May 6. Int J Mol Med. 2022. PMID: 35514302 Free PMC article. - The effects of IL-6 on CD4 T cell responses.
Dienz O, Rincon M. Dienz O, et al. Clin Immunol. 2009 Jan;130(1):27-33. doi: 10.1016/j.clim.2008.08.018. Epub 2008 Oct 8. Clin Immunol. 2009. PMID: 18845487 Free PMC article. Review. - IL-6 activated integrated BATF/IRF4 functions in lymphocytes are T-bet-independent and reversed by subcutaneous immunotherapy.
Koch S, Mousset S, Graser A, Reppert S, Übel C, Reinhardt C, Zimmermann T, Rieker R, Lehr HA, Finotto S. Koch S, et al. Sci Rep. 2013;3:1754. doi: 10.1038/srep01754. Sci Rep. 2013. PMID: 23628948 Free PMC article. - IL-6 trans-signaling via the soluble IL-6 receptor: importance for the pro-inflammatory activities of IL-6.
Rose-John S. Rose-John S. Int J Biol Sci. 2012;8(9):1237-47. doi: 10.7150/ijbs.4989. Epub 2012 Oct 24. Int J Biol Sci. 2012. PMID: 23136552 Free PMC article. Review. - Blocking interleukin-6 trans-signaling protects against renal fibrosis by suppressing STAT3 activation.
Chen W, Yuan H, Cao W, Wang T, Chen W, Yu H, Fu Y, Jiang B, Zhou H, Guo H, Zhao X. Chen W, et al. Theranostics. 2019 May 31;9(14):3980-3991. doi: 10.7150/thno.32352. eCollection 2019. Theranostics. 2019. PMID: 31281526 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous